Which sedative is safer for elderly surgery patients? new trial investigates

NCT ID NCT07569614

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two sedative drugs—remimazolam and dexmedetomidine—to see which one better prevents postoperative delirium (sudden confusion) in patients aged 60 and older after thoracoscopic surgery. A total of 105 participants were randomly assigned to receive one of the two drugs or a placebo. The goal was to find a safer anesthesia option for older adults, who are at higher risk for delirium and related complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remimazolam tosylate and dexmedetomidine
What this could lead to
If successful, this could point toward a safer sedation option for elderly patients that lowers the risk of postoperative delirium.
What could go wrong
This is a small, completed trial with 105 participants, so results may not apply to all patients. Both drugs have known side effects like low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEXMEDETOMIDINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • First Affiliated Hospital of Kunming Medical University Kunming

    Kunming, Yunnan, 6500000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.